This spoke is the index, not another personal-risk card. The other two views of the same brain are the most valuable outbound links on this cluster.
No personal SNP cards · Sept 2026
SHORT VERSION
The report is a tool. These pages are a translation.
The platform calls itself decision support, not a diagnosis.
The other two views of the same brain still matter more than any single row.
If a word is confusing, the glossary is the first stop.
THE INDEX
What I actually took away, without another personal card.
The repeating shape
Two copies is the recurring theme. This is not a scatter of single-copy carriers. The homozygous list lives on the spokes, not as another personal card here.
Amyloid clearance is hit from four independent directions. That is why the response stacks instead of picking one.
Mind and meds
The catecholamine and serotonin systems are the mental-health story. The practical read-through is a printed skepticism about SSRIs and 5-HTP for this genotype.
Pharmacogenomics is where this report is most actionable, and most flags are negative.
Caffeine is called out three times, and coffee is recommended once. The tension stays unresolved.
What the report will not pretend
Nutrient status can look normal on labs and still be wrong in the brain.
The report contains internal conflicts and does not hide them. A genetics page that presents itself as certain is dishonest.
One clean benefit — Clusterin (Apolipoprotein J)
Helps clear amyloid from inside the cell, affects inflammation and immune responses, and carriers have an associated decreased risk for Alzheimer’s, especially when combined with MS4A4E. I am putting the bright line here so the cluster is not unrelievedly negative.
Report components: Hot Spot Summary, Cognition & Memory, Mental Wellness, Medical Overview, Clinician Summary & Action Plan.